Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. The company is developing Olinciguat, an orally administered vascular...
14 insider purchases on record · latest filing 2021-06-07.
Insiders have also filed 10 sale transactions at CYCN.